Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Resource Type
Article
Authors
Abou-Alfa, Ghassan K ; Macarulla, Teresa ; Javle, Milind M ; Kelley, Robin K ; Lubner, Sam J ; Adeva, Jorge ; Cleary, James M ; Catenacci, Daniel V ; Borad, Mitesh J ; Bridgewater, John ; Harris, William P ; Murphy, Adrian G ; Oh, Do-Youn ; Whisenant, Jonathan ; Lowery, Maeve A ; Goyal, Lipika ; Shroff, Rachna T ; El-Khoueiry, Anthony B ; Fan, Bin ; Wu, Bin ; Chamberlain, Christina X ; Jiang, Liewen ; Gliser, Camelia ; Pandya, Shuchi S ; Valle, Juan W ; Zhu, Andrew X
Source
In The Lancet Oncology June 2020 21(6):796-807
Subject
Primary Research Articles
Language
ISSN
1470-2045